XERS — Xeris Biopharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Xeris Biopharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	75.5	134	102	122	72.5
Net Total Accounts Receivable
Net Total Receivables	5.64	6.88	17.5	30.8	39.2
Total Inventory
Prepaid Expenses
Total Current Assets	87.5	152	143	187	156
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.85	6.71	6.63	9.51	29.2
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	109	159	304	345	323
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	27.3	28.2	79	73.6	95.2
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	94.6	125	209	299	329
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14.4	33.8	95.2	45.2	-6.78
Total Liabilities & Shareholders' Equity	109	159	304	345	323
Total Common Shares Outstanding